YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Regulators approve first new depression drug since 1980s

Posted online

The U.S. Food and Drug Administration yesterday approved the first new depression medication since the 1980s.

Johnson & Johnson's new drug Spravato is the brand name for esketamine, a nasal spray designed to treat severe forms of depression.

It contains the chemical mirror image of ketamine, which is used for its psychedelic effects.

Read more from Business Insider.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences